Insider Trading (Form 4)
NASDAQ
Globalink Investment Inc. and Alps Life Sciences Inc. amended their merger agreement, adjusting escrow share contributions and extending the shareholder consent deadline.
Delay expected
Worse than expected
Schedule 13D - Activist Investments
NASDAQ
Alps Group Inc.'s CEO, Dr. THAM Seng Kong, has disclosed beneficial ownership of 46.36% of the company's ordinary shares following a $1.6 billion merger.
Capital raise
Schedule 13G - Passive Investments
NASDAQ
Lim Kuang Sia has reported a beneficial ownership of 10.32% of Alps Group Inc's Ordinary Shares.
NASDAQ
Crystal Propel Sdn. Bhd. and Hock Keat Ong have disclosed a passive 9.46% beneficial ownership in Alps Group Inc.